Total Payments
$19,339
2024 Payments
$3,520
Companies
46
Transactions
1,036
Medicare Patients
3,237
Medicare Billing
$647,941
Payment Breakdown by Category
Food & Beverage$19,275 (99.7%)
Education$63.84 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,275 | 1,032 | 99.7% |
| Education | $63.84 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,892 | 204 | $0 (2024) |
| ABBVIE INC. | $3,467 | 171 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,737 | 99 | $0 (2024) |
| PFIZER INC. | $1,653 | 123 | $0 (2024) |
| Lilly USA, LLC | $1,261 | 54 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,111 | 56 | $0 (2024) |
| UCB, Inc. | $868.76 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $770.87 | 40 | $0 (2024) |
| Celgene Corporation | $529.52 | 33 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $412.05 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,520 | 156 | Amgen Inc. ($842.69) |
| 2023 | $2,868 | 140 | AbbVie Inc. ($1,022) |
| 2022 | $2,772 | 150 | ABBVIE INC. ($695.82) |
| 2021 | $514.37 | 25 | Amgen Inc. ($189.87) |
| 2020 | $566.12 | 31 | Amgen Inc. ($114.99) |
| 2019 | $3,020 | 173 | Amgen Inc. ($531.16) |
| 2018 | $2,988 | 185 | PFIZER INC. ($506.60) |
| 2017 | $3,090 | 176 | Amgen Inc. ($563.93) |
All Payment Transactions
1,036 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $32.86 | General |
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $32.95 | General |
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Analgesic | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 10/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Analgesic | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: OSTEOPOROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 798 | 39,747 | $897,231 | $263,473 |
| 2022 | 17 | 739 | 21,927 | $571,463 | $177,822 |
| 2021 | 22 | 814 | 2,576 | $222,386 | $103,397 |
| 2020 | 26 | 886 | 2,904 | $270,045 | $103,249 |
Total Patients
3,237
Total Services
67,154
Medicare Billing
$647,941
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 11 | 35,600 | $540,000 | $139,136 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 480 | $165,600 | $49,064 | 29.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 24 | 2,400 | $81,600 | $43,946 | 53.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 86 | $41,710 | $12,016 | 28.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 88 | $17,072 | $5,117 | 30.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 25 | 51 | $10,001 | $3,127 | 31.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 219 | $8,541 | $2,731 | 32.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,683 | $2,095 | 27.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 68 | 142 | $1,846 | $1,193 | 64.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 61 | 115 | $3,680 | $1,190 | 32.3% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 14 | 23 | $3,480 | $949.40 | 27.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 57 | 113 | $4,859 | $859.93 | 17.7% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 63 | 136 | $3,264 | $690.88 | 21.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 19 | 20 | $1,700 | $580.20 | 34.1% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 15 | 37 | $2,035 | $435.12 | 21.4% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 43 | 51 | $1,479 | $135.15 | 9.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 144 | $2,304 | $117.09 | 5.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 17 | 29 | $377.00 | $90.19 | 23.9% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 19,600 | $294,000 | $88,008 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 420 | $144,900 | $43,043 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 105 | $50,925 | $16,435 | 32.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 900 | $30,600 | $15,716 | 51.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $10,047 | $3,239 | 32.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 21 | 46 | $8,924 | $2,946 | 33.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 20 | 38 | $7,877 | $2,455 | 31.2% |
About Dr. Catherine Driver, M.D
Dr. Catherine Driver, M.D is a Rheumatology healthcare provider based in Mission Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356469266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Driver, M.D has received a total of $19,339 in payments from pharmaceutical and medical device companies, with $3,520 received in 2024. These payments were reported across 1,036 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($19,275).
As a Medicare-enrolled provider, Driver has provided services to 3,237 Medicare beneficiaries, totaling 67,154 services with total Medicare billing of $647,941. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Mission Viejo, CA
- Active Since 03/27/2007
- Last Updated 10/21/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1356469266
Products in Payments
- Enbrel (Biological) $2,939
- RINVOQ (Biological) $1,523
- COSENTYX (Biological) $1,197
- XELJANZ (Drug) $1,092
- BENLYSTA (Biological) $1,088
- Cimzia (Drug) $868.76
- TALTZ (Drug) $857.02
- SKYRIZI (Biological) $810.64
- Humira (Biological) $756.42
- Otezla (Drug) $617.62
- TREMFYA (Drug) $400.37
- ORENCIA (Biological) $394.34
- COSENTYX (Drug) $386.97
- SAPHNELO (Biological) $342.87
- EVENITY (Biological) $315.37
- FORTEO (Drug) $295.96
- LYRICA (Drug) $286.25
- Rasuvo (Drug) $283.19
- OFEV (Drug) $281.83
- KRYSTEXXA (Biological) $217.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Mission Viejo
Dr. Willilam Shiel, M.d, M.D
Rheumatology — Payments: $927,424
Rheumatology $927,424
Dr. Hernan Castro-Rueda, M.d, M.D
Rheumatology — Payments: $25,626
Rheumatology $25,626
Simranjit Singh, Md, MD
Rheumatology — Payments: $9,964
Rheumatology $9,964
Dr. Fatemeh Jafari Farshami, M.d, M.D
Rheumatology — Payments: $4,323
Rheumatology $4,323
Dr. Paul Wehrle, M.d, M.D
Rheumatology — Payments: $257.06
Rheumatology $257.06